IP Library › Granted Patent US 10,183,015
Granted Patent B2
US 10,183,015 · App. 15/553,589 · Granted Jan 22, 2019

Heterocyclic compounds and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,183,015
App. No.
15/553,589
Granted
Jan 22, 2019
Kind
B2
Abstract

This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (NASH); elevated cholesterol levels, and insulin resistance.

Claims (4)

1. A method of treating liver fibrosis, comprising administering to a patient in need thereof an effective amount of the compound

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the patient has non-alcoholic steatohepatitis (NASH).

3. The method of claim 1 , wherein administration of the compound or the pharmaceutically acceptable salt of the compound reduces the risk of NASH in the patient.

Assignments (2)
CHANGE OF NAME Recorded Oct 26, 2017
From: MEDIVATION TECHNOLOGIES, INC.
To: MEDIVATION TECHNOLOGIES LLC
Reel/Frame 044617/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2017
From: BERNALES, SEBASTIAN; LINDQUIST, JEFFREY; GUHA, MAUSUMEE
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 043400/0562 →